These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29721184)

  • 1. Correlation between lower balance of Th2 helper T-cells and expression of PD-L1/PD-1 axis genes enables prognostic prediction in patients with glioblastoma.
    Takashima Y; Kawaguchi A; Kanayama T; Hayano A; Yamanaka R
    Oncotarget; 2018 Apr; 9(27):19065-19078. PubMed ID: 29721184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL.
    Takashima Y; Kawaguchi A; Sato R; Yoshida K; Hayano A; Homma J; Fukai J; Iwadate Y; Kajiwara K; Ishizawa S; Hondoh H; Nakano M; Ogawa S; Tashiro K; Yamanaka R
    Sci Rep; 2019 Jul; 9(1):10004. PubMed ID: 31292525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 expression and prognostic impact in glioblastoma.
    Nduom EK; Wei J; Yaghi NK; Huang N; Kong LY; Gabrusiewicz K; Ling X; Zhou S; Ivan C; Chen JQ; Burks JK; Fuller GN; Calin GA; Conrad CA; Creasy C; Ritthipichai K; Radvanyi L; Heimberger AB
    Neuro Oncol; 2016 Feb; 18(2):195-205. PubMed ID: 26323609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells.
    Loke P; Allison JP
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5336-41. PubMed ID: 12697896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer.
    Pichler R; Gruenbacher G; Culig Z; Brunner A; Fuchs D; Fritz J; Gander H; Rahm A; Thurnher M
    Cancer Immunol Immunother; 2017 Apr; 66(4):427-440. PubMed ID: 28005163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential control of CD4(+) T-cell subsets by the PD-1/PD-L1 axis in a mouse model of allergic asthma.
    McAlees JW; Lajoie S; Dienger K; Sproles AA; Richgels PK; Yang Y; Khodoun M; Azuma M; Yagita H; Fulkerson PC; Wills-Karp M; Lewkowich IP
    Eur J Immunol; 2015 Apr; 45(4):1019-29. PubMed ID: 25630305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Implications of TCGA Network Data on 2nd Generation Immunotherapy Concepts Based on PD-L1 and PD-1 Target Structures].
    Peters I; Tezval H; Kramer MW; Wolters M; Grünwald V; Kuczyk MA; Serth J
    Aktuelle Urol; 2015 Nov; 46(6):481-5. PubMed ID: 26560846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.
    Tosolini M; Kirilovsky A; Mlecnik B; Fredriksen T; Mauger S; Bindea G; Berger A; Bruneval P; Fridman WH; Pagès F; Galon J
    Cancer Res; 2011 Feb; 71(4):1263-71. PubMed ID: 21303976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis B e antigen from chronic hepatitis B patients induces Th1/Th2 cytokine imbalance in vitro].
    Han YP; Li J; Jiang LF; Xu QQ; Liu B; Dong L; Chen N; Kong LH; Xie FR; Huang ZH
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):584-9. PubMed ID: 24119737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of PD-L1 expression in tumor infiltrating immune cells in cancers: A meta-analysis.
    Zhao T; Li C; Wu Y; Li B; Zhang B
    PLoS One; 2017; 12(4):e0176822. PubMed ID: 28453554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome.
    Miyazaki T; Ishikawa E; Matsuda M; Akutsu H; Osuka S; Sakamoto N; Takano S; Yamamoto T; Tsuboi K; Matsumura A
    J Neurooncol; 2017 Jun; 133(2):277-285. PubMed ID: 28447277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmed death-1
    Singh A; Mohan A; Dey AB; Mitra DK
    Clin Exp Immunol; 2017 Feb; 187(2):269-283. PubMed ID: 27665733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva.
    Howitt BE; Sun HH; Roemer MG; Kelley A; Chapuy B; Aviki E; Pak C; Connelly C; Gjini E; Shi Y; Lee L; Viswanathan A; Horowitz N; Neuberg D; Crum CP; Lindeman NL; Kuo F; Ligon AH; Freeman GJ; Hodi FS; Shipp MA; Rodig SJ
    JAMA Oncol; 2016 Apr; 2(4):518-22. PubMed ID: 26913631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of PD-L1 in bladder cancer.
    Huang Y; Zhang SD; McCrudden C; Chan KW; Lin Y; Kwok HF
    Oncol Rep; 2015 Jun; 33(6):3075-84. PubMed ID: 25963805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients.
    Arrieta O; Montes-Servín E; Hernandez-Martinez JM; Cardona AF; Casas-Ruiz E; Crispín JC; Motola D; Flores-Estrada D; Barrera L
    Oncotarget; 2017 Nov; 8(60):101994-102005. PubMed ID: 29254220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic Analysis of PD-L1 and PD-L2 Expression in Renal Cell Carcinoma: Association with Oncogenic Proteins Status.
    Shin SJ; Jeon YK; Kim PJ; Cho YM; Koh J; Chung DH; Go H
    Ann Surg Oncol; 2016 Feb; 23(2):694-702. PubMed ID: 26464193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
    Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
    Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of PD-1, PD-L1, and PD-L2 expression in pediatric solid tumors.
    Pinto N; Park JR; Murphy E; Yearley J; McClanahan T; Annamalai L; Hawkins DS; Rudzinski ER
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28488345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors.
    Danilova L; Wang H; Sunshine J; Kaunitz GJ; Cottrell TR; Xu H; Esandrio J; Anders RA; Cope L; Pardoll DM; Drake CG; Taube JM
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):E7769-E7777. PubMed ID: 27837027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical correlation of peripheral CD4+‑cell sub‑sets, their imbalance and Parkinson's disease.
    Chen Y; Qi B; Xu W; Ma B; Li L; Chen Q; Qian W; Liu X; Qu H
    Mol Med Rep; 2015 Oct; 12(4):6105-11. PubMed ID: 26239429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.